News from intravacc b.v. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 23, 2021, 02:00 ET Intravacc announces formation of Scientific Advisory Board

Intravacc, a world leader in translational research and development of vaccines, today announced the formation of a Scientific Advisory Board...

Feb 19, 2021, 06:17 ET Dutch Intravacc starts concept design for multifunctional, high-capacity vaccine plant for national requirement

Intravacc, a world leader in translational research and development of vaccines, today announced that its new modern pilot production plant will soon ...

Jan 19, 2021, 03:00 ET Intravacc announces completion of formulation and manufacturing process development of PRV-101 vaccine candidate for Provention Bio

Intravacc, a world leader in translational research and development of vaccines, today announced that a candidate polyvalent inactivated...

Jan 06, 2021, 03:00 ET Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms

Intravacc, a world leader in translational research and development of vaccines, and Cristal Therapeutics, a technology leader in enabling safer and...

Dec 22, 2020, 01:00 ET Dutch Vaccine developer Intravacc becomes public shareholding company effective January 1, 2021

Intravacc, one of the world's leading translational research and development vaccine organisations, with an extensive track record in developing...

Nov 16, 2020, 03:00 ET Intravacc publishes positive phase I Shigella conjugate vaccine data

Intravacc, one of the leading translational research and development vaccine institutes with an extensive track record in developing viral and...

Nov 05, 2020, 06:59 ET Intravacc appoints Prof. Dr. Virgil Schijns as Chief Scientific Officer

Intravacc, a global leading contract development and manufacturing organization of viral and bacterial vaccines, today announced the appointment of...

Sep 08, 2020, 02:00 ET Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine

Intravacc, a global leader in translational research and development of viral and bacterial vaccines, today announced that it has been awarded a...

Aug 25, 2020, 02:00 ET Intravacc and Therapyx jointly develop the world's first prophylactic gonorrhea vaccine

Intravacc, a global leader in translational research and development of viral and bacterial vaccines, has partnered with American, Buffalo, NY, based ...

Jul 29, 2020, 05:39 ET Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine

Intravacc, a global leader in translational research and development of viral and bacterial vaccines, and Celonic Group, a premium biopharmaceutical...

Jun 22, 2020, 02:00 ET Intranasal Immunization with Intravacc's Experimental Whooping Cough Vaccine Confers Broad Protection

Intravacc, one of the leading translational research and development vaccine institutes with an extensive track record in developing viral and...

Jun 08, 2020, 03:00 ET Intravacc and Versatope Sign Research Service Agreement to Develop Universal Influenza Vaccine Based on OMV technology

Intravacc, one of the leading translational research and development vaccine institutes with an extensive track record in developing viral and...

Jun 04, 2020, 08:00 ET Intravacc Partners With Wageningen Bioveterinary Research and Utrecht University to Develop an Intranasal COVID-19 Vaccine

Intravacc, one of the world's leading translational research and development vaccine institutes, with an extensive track record in developing viral...